Article
Association of KRAS variants with survival and therapeutic outcomes in biliary tract cancers.
ESMO open - 1 Jun 2025
Iida K, Matsui Y, Urabe Y, Muramatsu T, Matsuzaki J, Saito Y
Abstract excerpt
BACKGROUND: Biliary tract cancer (BTC) remains a highly aggressive malignancy with limited treatment options and poor prognosis. To explore the association between KRAS variants and survival/therapeutic outcomes of patients with BTC, we analyzed genetic and clinical data obtained from BTC patients who underwent comprehensive genomic profiling (CGP) testing in Japan. PATIENTS AND METHODS: A total of 7773 patients...
Read the complete abstract on PubMedTopics
- Humans
- Proto-Oncogene Proteins p21(ras)
- Male
- Female
- Biliary Tract Neoplasms
- Aged
- Middle Aged
